The fact that OSCC patients and healthy control persons do not differ regarding their PD-L1 expression in peripheral blood indicates that a tumor-independent, preexisting state of immune surveillance or PD-L1 mediated immune tolerance might enable the formation of metastases in a certain subgroup of individuals. This evidence concerns the gene CD274 and neoplasm.